The research report, titled “Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” states that the decreasing rate of hospital visits of elderly people across the world is impacting the global hospital pharmaceuticals market negatively. Additionally, the imminent patent expiry of blockbuster drugs is anticipated to trigger the decline of this market during the forecast period.
Browse the full Hospital Pharmaceuticals Market (Cardiology, Oncology, Nephrology & Urology, Neurology, pain and Infection) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at https://www.transparencymarketresearch.com/hospital-pharmaceuticals-market.html
Transparency Market Research (TMR) has recently published a market study on the global hospital pharmaceuticals market and estimated it to decline at a CAGR of -10.50% during the period from 2014 to 2020.The worldwide hospital pharmaceuticals market stood at US$26.5 bn in 2013. Analysts at TMR expect it to drop down to US$11.6 bn by the end of the forecast period.
The global market, however, may gain a bit of traction on account of the increasing visits of patients to the emergency department of hospitals, states the market study.The research report evaluates the global hospital pharmaceuticals market on the basis of therapeutic class, indication, and its regional spread. Based on the indication, the global market has been segmented into cardiology, urology and nephrology, oncology, neurology, infection, and pain. Further, the market has been classified into the various therapeutic classes prescribed for these indications.
Among these, the oncology segment dominated the overall market in 2013. In the oncology segment, the immunomodulating agents drug class accounts for the highest share. The cardiology segment holds the second position in the global hospital pharmaceuticals market, says the report.
Regionally, the global hospital pharmaceuticals market has been segmented into Asia Pacific, Europe, North America, and the Rest of the World in this report. North America led the worldwide market in 2013. However, Asia Pacific is likely to overtake North America during the forecast period.
As per the research report, the rising patient pool suffering from cancer, cardiovascular disorders, and other chronic diseases, and the huge population base in this region are the prime factors behind the growth of the hospital pharmaceuticals market in Asia Pacific.In addition to this, the increasing number of hospitals in Asian countries, together with the growing awareness regarding branded drugs utilized for the treatment of chronic diseases, is likely to boost the demand for hospital pharmaceuticals in this region.
The hospital pharmaceuticals market in the Rest of the World is also expected to witness a surge in its market share over the forecast period, owing to the remarkable rise of medical tourism, notes the market study.AstraZeneca plc, Bristol-Myers Squibb Co., Bayer AG, Eli Lilly and Co., Johnson & Johnson, GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer Inc., Novartis AG, and Sanofi-Aventis are some of the major manufacturers of hospital pharmaceutical products in the global arena, states the research report.
The global hospital pharmaceuticals market is segmented into:
By Therapeutic Class
Nephrology and Urology
Nephrology and Urology
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453